Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 09-Oct-24 5:00 PM View:  | Baranick Brian EVP, GM, Precision Oncology | EXACT Sciences Corp. (EXAS) | 08-Oct-24 | Market Sale (Planned) | 929 | $70.00 | $65,030.00 | (7%) 14.14K to 13.21K | (6%) |
| 19-Sep-24 5:00 PM View: | Baranick Brian EVP, GM, Precision Oncology | EXACT Sciences Corp. (EXAS) | 18-Sep-24 | Market Sale (Planned) | 929 | $70.00 | $65,030.00 | (6%) 15.07K to 14.14K | (6%) |
| 06-Aug-24 5:30 PM View: | Baranick Brian EVP, GM, Precision Oncology | EXACT Sciences Corp. (EXAS) | 05-Aug-24 | Payment of Exercise | 1,375 | $55.77 | $76,683.80 | (8%) 16.45K to 15.07K | |
| 06-Aug-24 5:30 PM View: | Baranick Brian EVP, GM, Precision Oncology | EXACT Sciences Corp. (EXAS) | 05-Aug-24 | Option Exercise | 2,712 | -- | -- | 20% 13.73K to 16.45K | |
| 17-Jun-24 5:30 PM View: | Sebelius Kathleen Director | EXACT Sciences Corp. (EXAS) | 13-Jun-24 | Grant | 6,889 | -- | -- | 28% 25.0K to 31.89K | |
| 17-Jun-24 5:30 PM View: | Clancy Paul J Director | EXACT Sciences Corp. (EXAS) | 13-Jun-24 | Grant | 5,444 | -- | -- | 37% 14.7K to 20.14K | |
| 17-Jun-24 5:30 PM View: | Doyle James Edward Director | EXACT Sciences Corp. (EXAS) | 13-Jun-24 | Grant | 5,444 | -- | -- | 11% 50.11K to 55.55K | |
| 17-Jun-24 5:30 PM View: | Levangie Daniel J Director | EXACT Sciences Corp. (EXAS) | 13-Jun-24 | Grant | 5,444 | -- | -- | 24% 22.98K to 28.42K | |
| 17-Jun-24 5:30 PM View: | Napier Katherine S Director | EXACT Sciences Corp. (EXAS) | 13-Jun-24 | Grant | 5,444 | -- | -- | 8% 64.63K to 70.07K | |
| 17-Jun-24 5:30 PM View: | Petrovic Shacey Director | EXACT Sciences Corp. (EXAS) | 13-Jun-24 | Grant | 5,444 | -- | -- | 31% 17.56K to 23.01K | |
| 17-Jun-24 5:30 PM View: | Coward D Scott Director | EXACT Sciences Corp. (EXAS) | 13-Jun-24 | Grant | 5,444 | -- | -- | 11% 49.34K to 54.78K | |
| 17-Jun-24 5:30 PM View: | Barber Michael J Director | EXACT Sciences Corp. (EXAS) | 13-Jun-24 | Grant | 5,444 | -- | -- | 100% 0 to 5.44K | |
| 02-May-24 7:00 PM View: | Conroy Kevin T President and CEO Director | EXACT Sciences Corp. (EXAS) | 01-May-24 | Sale (Planned) | 1,155 | $60.15 | $69,473.20 | (< 1%) 1.21M to 1.21M | |
| 02-May-24 7:00 PM View: | Elliott Jeffrey Thomas Chief Financial Officer | EXACT Sciences Corp. (EXAS) | 01-May-24 | Sale (Planned) | 136 | $60.15 | $8,180.40 | (1%) 13.52K to 13.38K | |
| 02-May-24 7:00 PM View: | Orville Jacob A General Manager, Screening | EXACT Sciences Corp. (EXAS) | 01-May-24 | Sale (Planned) | 102 | $60.15 | $6,135.30 | (< 1%) 15.66K to 15.56K | |
| 02-May-24 7:00 PM View: | Coward D Scott Director | EXACT Sciences Corp. (EXAS) | 01-May-24 | Sale (Planned) | 67 | $60.15 | $4,030.05 | (< 1%) 49.4K to 49.34K | |
| 02-May-24 7:00 PM View: | Herriott James SVP, General Counsel & Sec | EXACT Sciences Corp. (EXAS) | 01-May-24 | Sale (Planned) | 30 | $60.15 | $1,804.50 | (< 1%) 11.08K to 11.05K | |
| 02-May-24 7:00 PM View: | Cunningham Everett Chief Commercial Officer | EXACT Sciences Corp. (EXAS) | 01-May-24 | Sale (Planned) | 136 | $60.15 | $8,180.40 | (< 1%) 47.75K to 47.61K | |
| 02-May-24 7:00 PM View: | Condella Sarah EVP, Human Resources | EXACT Sciences Corp. (EXAS) | 01-May-24 | Sale (Planned) | 102 | $60.15 | $6,135.30 | (< 1%) 78.44K to 78.34K | |
| 02-May-24 7:00 PM View: | Baranick Brian EVP, GM., Precision Oncology | EXACT Sciences Corp. (EXAS) | 01-May-24 | Sale (Planned) | 110 | $60.15 | $6,616.50 | (< 1%) 13.84K to 13.73K | |
| 02-May-24 7:00 PM View: | Elliott Jeffrey Thomas Chief Financial Officer | EXACT Sciences Corp. (EXAS) | 30-Apr-24 | Grant | 998 | $21.27 | $21,224.10 | 8% 12.52K to 13.52K | |
| 02-May-24 7:00 PM View: | Conroy Kevin T President and CEO Director | EXACT Sciences Corp. (EXAS) | 30-Apr-24 | Grant | 3,197 | $6.65 | $21,254.20 | < 1% 1.2M to 1.21M | |
| 02-May-24 7:00 PM View: | Orville Jacob A General Manager, Screening | EXACT Sciences Corp. (EXAS) | 30-Apr-24 | Grant | 218 | -- | -- | 1% 15.44K to 15.66K | |
| 02-May-24 7:00 PM View: | Baranick Brian EVP, GM., Precision Oncology | EXACT Sciences Corp. (EXAS) | 30-Apr-24 | Grant | 218 | -- | -- | 2% 13.63K to 13.84K | |
| 02-May-24 7:00 PM View: | Herriott James SVP, General Counsel & Sec | EXACT Sciences Corp. (EXAS) | 30-Apr-24 | Grant | 771 | $27.57 | $21,254.20 | 7% 10.31K to 11.08K | |
| 02-May-24 7:00 PM View: | Coward D Scott Director | EXACT Sciences Corp. (EXAS) | 30-Apr-24 | Grant | 218 | -- | -- | < 1% 49.19K to 49.4K | |
| 02-May-24 7:00 PM View: | Condella Sarah EVP, Human Resources | EXACT Sciences Corp. (EXAS) | 30-Apr-24 | Grant | 926 | $22.95 | $21,254.20 | 1% 77.51K to 78.44K | |
| 02-May-24 7:00 PM View: | Cunningham Everett Chief Commercial Officer | EXACT Sciences Corp. (EXAS) | 30-Apr-24 | Grant | 999 | $21.28 | $21,254.20 | 2% 46.75K to 47.75K | |
| 03-Apr-24 7:30 PM View: | Baranick Brian EVP, GM., Precision Oncology | EXACT Sciences Corp. (EXAS) | 02-Apr-24 | Market Sale (Planned) | 924 | $79.43 | $73,393.30 | (6%) 14.55K to 13.63K | 6% |
| 03-Apr-24 7:30 PM View: | Condella Sarah EVP, Human Resources | EXACT Sciences Corp. (EXAS) | 01-Apr-24 | Market Sale (Planned) | 2,000 | $70.00 | $140,000.00 | (3%) 79.51K to 77.51K | (6%) |
| 01-Apr-24 4:30 PM View: | Condella Sarah EVP, Human Resources | EXACT Sciences Corp. (EXAS) | 28-Mar-24 | Market Sale (Planned) | 2,000 | $70.00 | $140,000.00 | (2%) 81.51K to 79.51K | (6%) |
| 04-Mar-24 8:40 PM View: | Elliott Jeffrey Thomas Chief Financial Officer | EXACT Sciences Corp. (EXAS) | 01-Mar-24 | Planned Option Sale | 2,412 | $59.32 | $143,080.00 | (16%) 14.93K to 12.52K | |
| 04-Mar-24 8:42 PM View: | Orville Jacob A General Manager, Screening | EXACT Sciences Corp. (EXAS) | 01-Mar-24 | Planned Option Sale | 2,154 | $59.32 | $127,775.00 | (12%) 17.59K to 15.44K | |
| 04-Mar-24 8:38 PM View: | Cunningham Everett Chief Commercial Officer | EXACT Sciences Corp. (EXAS) | 01-Mar-24 | Planned Option Sale | 2,412 | $59.32 | $143,080.00 | (5%) 49.16K to 46.75K | |
| 04-Mar-24 8:41 PM View: | Herriott James General Counsel | EXACT Sciences Corp. (EXAS) | 01-Mar-24 | Planned Option Sale | 862 | $59.32 | $51,133.80 | (8%) 11.17K to 10.31K | |
| 04-Mar-24 8:37 PM View: | Condella Sarah EVP, Human Resources | EXACT Sciences Corp. (EXAS) | 01-Mar-24 | Planned Option Sale | 1,724 | $59.32 | $102,268.00 | (2%) 83.24K to 81.51K | |
| 04-Mar-24 8:36 PM View: | Baranick Brian Gen. Mgr., Precision Oncology | EXACT Sciences Corp. (EXAS) | 01-Mar-24 | Planned Option Sale | 2,323 | $59.32 | $137,800.00 | (14%) 16.87K to 14.55K | |
| 04-Mar-24 8:38 PM View: | Conroy Kevin T President and CEO Director | EXACT Sciences Corp. (EXAS) | 01-Mar-24 | Planned Option Sale | 8,271 | $59.32 | $490,636.00 | (< 1%) 1.36M to 1.35M | |
| 04-Mar-24 8:39 PM View: | Doyle James Edward Director | EXACT Sciences Corp. (EXAS) | 01-Mar-24 | Sale (Planned) | 2,000 | $57.50 | $115,000.00 | (4%) 52.11K to 50.11K | |
| 04-Mar-24 8:42 PM View: | Levangie Daniel J Director | EXACT Sciences Corp. (EXAS) | 01-Mar-24 | Sale (Planned) | 5,000 | $57.50 | $287,500.00 | (18%) 27.98K to 22.98K | |
| 04-Mar-24 8:36 PM View: | Baranick Brian Gen. Mgr., Precision Oncology | EXACT Sciences Corp. (EXAS) | 29-Feb-24 | Option Exercise | 4,724 | -- | -- | 39% 12.15K to 16.87K | |
| 04-Mar-24 8:38 PM View: | Conroy Kevin T President and CEO Director | EXACT Sciences Corp. (EXAS) | 29-Feb-24 | Option Exercise | 18,143 | -- | -- | 1% 1.34M to 1.36M | |
| 04-Mar-24 8:38 PM View: | Cunningham Everett Chief Commercial Officer | EXACT Sciences Corp. (EXAS) | 29-Feb-24 | Option Exercise | 5,291 | -- | -- | 12% 43.87K to 49.16K | |
| 04-Mar-24 8:40 PM View: | Elliott Jeffrey Thomas Chief Financial Officer | EXACT Sciences Corp. (EXAS) | 29-Feb-24 | Option Exercise | 5,291 | -- | -- | 55% 9.64K to 14.93K | |
| 04-Mar-24 8:42 PM View: | Orville Jacob A General Manager, Screening | EXACT Sciences Corp. (EXAS) | 29-Feb-24 | Option Exercise | 4,724 | -- | -- | 37% 12.87K to 17.59K | |
| 04-Mar-24 8:41 PM View: | Herriott James General Counsel | EXACT Sciences Corp. (EXAS) | 29-Feb-24 | Option Exercise | 1,890 | -- | -- | 20% 9.28K to 11.17K | |
| 04-Mar-24 8:37 PM View: | Condella Sarah EVP, Human Resources | EXACT Sciences Corp. (EXAS) | 29-Feb-24 | Option Exercise | 3,779 | -- | -- | 5% 79.46K to 83.24K | |
| 28-Feb-24 7:35 PM View: | Condella Sarah EVP, Human Resources | EXACT Sciences Corp. (EXAS) | 27-Feb-24 | Planned Option Sale | 1,880 | $56.89 | $106,953.00 | (2%) 81.34K to 79.46K | |
| 28-Feb-24 7:34 PM View: | Baranick Brian Gen. Mgr., Precision Oncology | EXACT Sciences Corp. (EXAS) | 27-Feb-24 | Planned Option Sale | 2,027 | $56.89 | $115,316.00 | (14%) 14.18K to 12.15K | |
| 28-Feb-24 7:35 PM View: | Conroy Kevin T President and CEO Director | EXACT Sciences Corp. (EXAS) | 27-Feb-24 | Planned Option Sale | 6,263 | $56.89 | $356,302.00 | (< 1%) 1.35M to 1.34M |
